The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen

被引：6

作者：

Bugla-Ploskonska, G. ^{[1
]}

Cisowska, A.

Karpinska, K.

Jankowski, S.

Doroszkiewicz, W.

机构：

[1] Univ Wroclaw, Inst Genet & Microbiol, PL-51148 Wroclaw, Poland

[2] Med Univ, Dept Biol & Med Parasitol, PL-50367 Wroclaw, Poland

来源：

FOLIA MICROBIOLOGICA | 2006年 / 51卷 / 06期

关键词：

D O I：

10.1007/BF02931630

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Ten E. coli K1 strains isolated from the urine of children with urinary tract infections were sensitive to the bactericidal action of normal human serum (NHS). The role of the particular mechanisms of complement: activation was determined in the process of killing these strains, showing variable sensitivity to the bactericidal action of NHS; three mechanisms of activation of human complement were observed. Important role of alternative pathway activation in the bactericidal action of NHS against E. coli K1 strains independent of the classical and lectin pathways was not established.

引用

页码：627 / 632

页数：6

共 26 条

[11] FINE DP, 1972, J IMMUNOL, V109, P807
[12] FRANICZEK R, 1993, ACTA MCIROBIOL POL, V3, P243
[13] Complement deficiencies
Frank, MM
[J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2000, 47 (06) : 1339 - +
[14] THE MECHANISM BY WHICH MICROORGANISMS AVOID COMPLEMENT ATTACK
FRANK, MM
[J]. CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (01) : 14 - 19
[15] Structure of the sialic acid-containing O-specific polysaccharide from Salmonella enterica serovar Toucra O48 lipopolysaccharide
Gamian, A
Jones, C
Lipinski, T
Korzeniowska-Kowal, A
Ravenscroft, N
[J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (11): : 3160 - 3166
[16] VIRULENCE FACTORS IN ESCHERICHIA-COLI URINARY-TRACT INFECTION
JOHNSON, JR
[J]. CLINICAL MICROBIOLOGY REVIEWS, 1991, 4 (01) : 80 - 128
[17] The (α2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum
Kahler, CM
Martin, LE
Shih, GC
Rahman, MM
Carlson, RW
Stephens, DS
[J]. INFECTION AND IMMUNITY, 1998, 66 (12) : 5939 - 5947
[18] Escherichia coli translocation at the blood-brain barrier
Kim, KS
[J]. INFECTION AND IMMUNITY, 2001, 69 (09) : 5217 - 5222
[19] THE CAPSULAR POLYSACCHARIDE IS A MAJOR DETERMINANT OF SERUM RESISTANCE IN K-1-POSITIVE BLOOD CULTURE ISOLATES OF ESCHERICHIA-COLI
LEYING, H
SUERBAUM, S
KROLL, HP
STAHL, D
OPFERKUCH, W
[J]. INFECTION AND IMMUNITY, 1990, 58 (01) : 222 - 227
[20] PREVENTION OF C3 DEPOSITION BY CAPSULAR POLYSACCHARIDE IS A VIRULENCE MECHANISM OF TYPE-III GROUP-B STREPTOCOCCI
MARQUES, MB
KASPER, DL
PANGBURN, MK
WESSELS, MR
[J]. INFECTION AND IMMUNITY, 1992, 60 (10) : 3986 - 3993

← 1 2 3 →